<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01765075</url>
  </required_header>
  <id_info>
    <org_study_id>STARLIGHT - 1012</org_study_id>
    <nct_id>NCT01765075</nct_id>
  </id_info>
  <brief_title>Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment</brief_title>
  <acronym>STARLIGHT</acronym>
  <official_title>Signal Transfer of Atrial Fibrillation Data to Guide Human Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Scientific Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Boston Scientific Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to gather electrophysiological data using a multi-electrode&#xD;
      mapping catheter during a clinically indicated cardiac ablation procedure for the treatment&#xD;
      of persistent atrial fibrillation.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Actual">February 2014</completion_date>
  <primary_completion_date type="Actual">February 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Record 20 sets of electrophysiological data with a multi-electrode mapping catheter.</measure>
    <time_frame>Acute - time of procedure</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Permanent Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>Patients undergoing cardiac ablation for permanent AF</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Permanent atrial fibrillation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 or above, or above legal age and willing and capable of giving informed consent&#xD;
             specific to national law&#xD;
&#xD;
          -  Scheduled for a clinically indicated cardiac ablation for the treatment of persistent&#xD;
             atrial fibrillation&#xD;
&#xD;
          -  Able to meet study requirements for follow-up visit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Permanent leads or presence of prosthetic or severely stenotic tricuspid or mitral&#xD;
             valves&#xD;
&#xD;
          -  Active systemic infection or sepsis&#xD;
&#xD;
          -  Echocardiographically confirmed presence of thrombus&#xD;
&#xD;
          -  Atrial thrombus, myxoma, inter-atrial baffle patch or occluder device for those&#xD;
             subjects in whom a transseptal approach is required&#xD;
&#xD;
          -  Subjects who cannot be anticoagulated or infused with heparinized saline&#xD;
&#xD;
          -  Heparin induced thrombocytopenia&#xD;
&#xD;
          -  Hemodynamic instability or shock&#xD;
&#xD;
          -  Atrial anatomy contradictory to catheter labeling or size indices&#xD;
&#xD;
          -  EF &lt; 35%&#xD;
&#xD;
          -  Subjects with an active heart failure decompensation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jas Gill, MA MD FRCP FACC</last_name>
    <role>Principal Investigator</role>
    <affiliation>Guys &amp; St. Thomas' Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Na Homolce</name>
      <address>
        <city>Prague</city>
        <zip>15030</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Guys &amp; St. Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 1YR</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <study_first_submitted>January 8, 2013</study_first_submitted>
  <study_first_submitted_qc>January 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2013</study_first_posted>
  <last_update_submitted>March 3, 2014</last_update_submitted>
  <last_update_submitted_qc>March 3, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 5, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Electrophysiological mapping</keyword>
  <keyword>Multi-electrode catheter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

